Bill Curtis developed Parkinson’s symptoms at the age of 45 in the year
2000. He discusses his experience with using ketones and other therapies.
Ketone Ester available at: https://www.ketoneaid.com/pr
Have questions? Email Frank at: frank@ketonaid.com
Dr. Amy Yasko has a PhD in Microbiology/Immunology/infectious Disease from Albany Medical College and has completed multiple postdoctoral fellowships at the Yale Medical center, Wilmot Cancer Center URMC and Pediatric Infectious Disease at URMC.
After working in biotechnology for 15 years. Dr. Amy shifted her focus to alternative halthcare. She has a Doctor of Natural Health, is a board-certified Alternative Medical Practitioner, a board certified Holistic Health Practitions and a Felllow of the American Association of Ingegrative Medicine.
Following the completion of her traiing in Natural Health Dr. Amy began giving in -person consultations in Bethel, Maine. This work laid the foundation for the Yasko Protocol over 20 years ago which was created to serve as a guide for individuals to built a personalized map for health and wellness by making choices grounded in science.
In this interview, Dr. Amy Yasko will discuss how the Yasko Protocol can be applied to those with neurological discorders, with a focus on Parkinson’s disease. The protocol emphasizes a data driven approach by using the results of non-invasive at-home test kits to help guide individuals on how to best support their unique system with the use of natural supplementation.
This interview is with naturopath John Coleman who has just released his new book:Rethinking Parkinsons Disease which is to date, the most thorough exploration of the etiological pathways (causes) leading to diagnosis with Parkinson’s disease or similar neuro disorders.
Rethinking Parkinson’s Disease explains how and why trauma, toxins and stealth infections create symptoms diagnosed as a “disease”, usually treated without any further investigation into prodromal history, early life, toxic load or the possibility of infection.
The major section of this work details strategies to create wellness and reverse the illness processes, much available to patients with little or no cost. There are sections on Western Allopathic Medical treatments (symptom control), Complementary Medical treatments and therapies to avoid.
Robert
My research over the past decade documents the stories of recovery of many individuals who have been successful in reversing some if not all of their Parkinson’s symptoms. More than 70 replays of interviews with these pioneers of recovery are available as replays here on the Parkinsons Recovery member radio show page. One early story of recovery was reported by John Coleman who was one of the first persons to successfully reverse his Parkinson’s symptoms during the mid 1990s. .
Given his own experience with recovery. Dr. Coleman is in the ideal position to help others traveling down the road to recovery. During this program he discusses and responds to the following questions:
Robert
Walter Mady discusses the importance of Physical Therapy for the Parkinson’s disease patient and the factors that have made the biggest difference in addressing his own Parkinson’s symptoms.
Walter Mady [wmady@comcast.net]
Click the arrow below to hear my interview with Bill McAnalley PhD who discusses why food can fix things that drugs cant. His discussion focuses on explaining the causes of Parkinson’s and the right foods to treat each cause.
Information about Dr. McAnballey’s company, is accessed by visiting  Aroga
Parkinson’s disease (PD), characterized with bradykinesia, static tremor, rigidity and disturbances in balance, is the second most common neuro-degenerative disorder. Alzheimer disease is first.
With the global trends in aging, the incidence of PD has increased year by year and the prevalence rate is up to 1–2% among the elderly over the age of 65 years. So far, there is still no exact cure for PD due to its diversity of etiology and complexity of symptoms.
Currently, Parkinson’s disease is treated with Levodopa and maybe Monamine, Oxidase Inhibitors (MOAs) or Acetylcholine inhibitors. Levodopa makes more Dopamine available for the dopamine receptor, MOAs increase the amount norepinephrine, dopamine and serotonin at their prospective receptors and acetylcholine inhibitors make more acetylcholine available to its receptor.
None of which address the physical cause of the disease.
The cause of PD has not been completely elucidated, but it has been generally acknowledged that the improvement of oxidative stress is one of the most important patho-physiological mechanisms.
Dr. Bill’s research has focused on stopping the causes of diseases like Parkinson’s by:
PD patients are in a state of oxidative stress. Oxidative stress is caused by the increase of free radicals in the organism, while the ability to eliminate free radicals is decreased at the same time. A large amount of lipid peroxide, such as Malondialdehyde (MDA), hydroxyl, carbonyl, etc., will cause cell death, which leads to neuronal apoptosis ultimately.
The mitochondria is the “power plant†and “energy conversion station†of cells. It also regulates the process of gene expression and apoptosis. Recent reports have suggested that mitochondrial dysfunction is closely related to a variety of neuro-degenerative diseases including PD.
Glutamate (Glu), Also, gamma-aminobutyric acid (GABA) and enkephalin can can produce excitotoxicity effects on nerve cells. Glutamate creates an excitatory effect on nerve cells, and is toxic when Dopa Amine neurons are fully or partially degenerated.
Neuroinflammation is a common and important pathological mechanism in nervous system diseases and different neurological diseases are involved in neuroinflammation at some stage. At present, it is believed that neuroinflammation was involved in an important cascade reaction in neuronal degeneration of PD.
When the central nervous system suffers from exogenous antigens stimulus, such as pathogenic microorganisms or foreign bodies, microglia will be rapidly activated. Then, the activated microglia cells can secrete various cytokines such as IL-1β, IL-2, IL-4, IL-6, TNF-α, and IFN-γ, etc. The cytokines cause neuroinflammation.
Parkinson’s is caused by the premature death of dopaminergic neurons by abnormal apoptosis activation. Energy for normal activities of brain cells comes directly from aerobic energy, and there is little energy storage. However once brain damage occurs, it will cause nerve cell apoptosis or death.
The Bcl-2 family of proteins regulate apoptosis. It is divided into two categories: anti-apoptosis gene (such as Bcl-2, Bcl-xL, Bcl-w, Bcl-1, etc.) and pro-apoptosis gene (such as Bax, Bak, Bad, Bid, etc.). Their ratio regulates apoptosis.
Misfolded and aggregated proteins play a key role in the pathogenesis of Parkinson’s Disease. Protein aggregates differ from disease to disease. This common characteristic shows that protein deposition is toxic to neurons.
Studies confirmed that the activity of the proteasome dropped substantially in substantia nigra of patients with PD, which weakened the ability of the substantia nigra to degrade α-syn and other proteins.
Nrf2 is a basic leucine zipper (bZIP) protein that regulates the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. Several drugs that stimulate the NFE2L2 pathway are being studied for treatment of diseases that are caused by oxidative stress.
Brahmi, Bacopa monnieri
Maca root powder, Lepidium meyenii (Walp.)
Tongkat Ali (Longjack), Eurycoma Longifolia
Turmeric root powder, Curcuma longa
Brahmi, Bacopa monnieri
Turmeric root powder, Curcuma longa
Wild Yam root, Dioscorea villosa
Noni Fruit, Morinda citrifolia
Amia powder, Emblica officinalis
Turmeric root powder, Curcuma longa
Mitochondrial Dysfunction in Neurodegeneration.
Chaga Mushroom, Inonotus Obliquus
Milk Thistle Seed Extract, Silybum marianum.
Tongkat Ali (Longjack), Eurycoma Longifolia
Dr. Bill offered suggestions on the products he recommended for persons diagnosed with Parkinson’s. He recommended three
Aroga products: (1) the Core (2) the Plus Brain and Nerve and (3) the Bone, Joint and Endocrine (which supports hormones). At a minimum. the Core would take top priority.
Information about these products and the opportunity to order is available at:
https://arogalife.com/parkinsons-recovery
Sadly, Aroga products can only be shipped to locations in the United States.
Robert Rodgers PhD
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me
References:
Front Pharmacol. 2017; 8: 634. The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson’s Disease.
Front Neurosci. 2018 Jul 10;12:466. Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration.
William Curtis talks about his efforts to understand how ketones have helped with his Parkinson’s symptoms.  He developed Parkinson’s symptoms at the age of 45 in the year 2000 and has been instrumental in collaborating with NIH researcher Richard Veech in Washington DC..
What follows are the questions I ask Bill during the interview today on Parkinsons Recovery Radio.
How did Parkinson’s affect your life?
What led you to experiment with ketosis?
After the ketogenic exercise, what did you do to find out more about how ketosis could help your Parkinson’s symptoms?
What is the purpose of fasting?
What is the purpose of the morning fat and coffee mixture?
What happens when you eat too much carbohydrate?
What happens when you eat too much protein?
Can exercise take you out of ketosis?
Can stress take you out of ketosis?
What supplements do you take to support ketosis?
What do you think is causing the improvement in symptoms?
Have you been able to cut back on the Parkinson’s medications?
What do you think is going on as far as the disease progression you personally are experiencing?
Where do you think the use of ketosis in Parkinson’s is going?
Robert
Diagnosed with Parkinson’s disease three years ago. Don McCammon developed his own compound to treat his symptoms. He has been symptom free for 2 1/2 years.
Don wrote an article describing his discovery. The name of the compound he developed is Syncolein. It is a natural product that does not require a medical prescription.
What is the main ingredient in his forumlation? It is Mannitol. What in the world is Mannitol? Listen to the show to find out!
For further information and to get your questions answered, email Don at:Â donmccammon@gmail.com
My guest today is Dr. Laurie Mischley ND who will be discussing her exciting research program and discoveries as they pertain to Parkinson’s disease. The focus of her work is on describing conditionally essential nutrients in Parkinson’s disease (PD), attempting to describe the nutritional status and requirements unique to individuals with neurodegenerative diseases. She has published on coenzyme Q10 deficiency in PD, completed her master’s thesis on lithium deficiency in PD, and is currently completing her doctoral dissertation on glutathione in PD. In 2013, she and her team completed a “Phase I Safety & Tolerability Study of Intranasal Glutathione in PD.â€
Dr. Mischley is a clinical research assistant professor at Bastyr University, where she is principal investigator of other PD studies including, “CAM Care in PD†and “Cannabis in PD Tremor.â€
Track you symptoms here:Â www.PROPD.org
Natural Pharmacist Ross Pelton R.Ph., Ph.D., CCN discusses the history and discovery of a remarkable new strain of probiotic bacteria that has been found to produce glutathione in humans. Glutathione is called The Master Antioxidant and also the Master Detox Agent in humans. This interview will also review the wide-ranging functions, effects and benefits of glutathione with special attention to how these effects can benefit Parkinson’s disease patients.
Ross is offering a free 8-page report to listeners that summarizes the discovery and history of Lactobacillus fermentum ME-3 and information about the importance of glutathione. Email Ross to request a copy of his 8-page report. Provide your first and last name in the email request. ross@naturalpharmacist.net